YTHDC1
Basic information
Region (hg38): 4:68310387-68350090
Links
Phenotypes
GenCC
Source:
- autism spectrum disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the YTHDC1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 2 | 0 |
Variants in YTHDC1
This is a list of pathogenic ClinVar variants found in the YTHDC1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-68314109-T-A | not specified | Uncertain significance (Oct 26, 2021) | ||
4-68314127-C-T | not specified | Uncertain significance (Jul 20, 2022) | ||
4-68314134-T-C | not specified | Uncertain significance (Sep 17, 2021) | ||
4-68314187-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
4-68314262-C-T | not specified | Uncertain significance (Mar 01, 2023) | ||
4-68318532-G-A | not specified | Uncertain significance (May 10, 2024) | ||
4-68318841-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
4-68318860-A-G | not specified | Uncertain significance (Jul 15, 2021) | ||
4-68320129-T-C | not specified | Uncertain significance (Jun 29, 2023) | ||
4-68322785-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
4-68332188-C-T | not specified | Uncertain significance (Mar 19, 2024) | ||
4-68332838-T-C | not specified | Uncertain significance (Aug 08, 2022) | ||
4-68337089-C-T | not specified | Likely benign (Jun 28, 2022) | ||
4-68337153-C-T | not specified | Uncertain significance (Sep 27, 2022) | ||
4-68337208-TTCC-T | YTHDC1-related disorder | Likely benign (Apr 25, 2023) | ||
4-68337242-T-C | not specified | Uncertain significance (Jan 04, 2022) | ||
4-68337328-T-A | not specified | Uncertain significance (Nov 12, 2021) | ||
4-68337344-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
4-68337614-A-T | not specified | Uncertain significance (Sep 12, 2023) | ||
4-68337624-C-T | not specified | Uncertain significance (May 26, 2023) | ||
4-68337642-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
4-68337654-T-C | not specified | Uncertain significance (Jul 12, 2022) | ||
4-68337693-C-T | not specified | Uncertain significance (Sep 22, 2022) | ||
4-68337774-C-T | not specified | Uncertain significance (May 09, 2022) | ||
4-68337825-A-G | not specified | Uncertain significance (Oct 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
YTHDC1 | protein_coding | protein_coding | ENST00000344157 | 17 | 39703 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 5.76e-8 | 125734 | 0 | 2 | 125736 | 0.00000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.48 | 269 | 410 | 0.656 | 0.0000230 | 4750 |
Missense in Polyphen | 23 | 75.937 | 0.30288 | 879 | ||
Synonymous | -0.355 | 135 | 130 | 1.04 | 0.00000626 | 1326 |
Loss of Function | 6.46 | 1 | 50.5 | 0.0198 | 0.00000353 | 543 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000178 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulator of alternative splicing that specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs (PubMed:26318451, PubMed:26876937, PubMed:25242552, PubMed:28984244). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in the efficiency of mRNA splicing, processing and stability (PubMed:26318451, PubMed:25242552). Acts as a key regulator of exon-inclusion or exon-skipping during alternative splicing via interaction with mRNA splicing factors SRSF3 and SRSF10 (PubMed:26876937). Specifically binds m6A-containing mRNAs and promotes recruitment of SRSF3 to its mRNA-binding elements adjacent to m6A sites, leading to exon-inclusion during alternative splicing (PubMed:26876937). In contrast, interaction with SRSF3 prevents interaction with SRSF10, a splicing factor that promotes exon skipping: this prevents SRSF10 from binding to its mRNA-binding sites close to m6A-containing regions, leading to inhibit exon skipping during alternative splicing (PubMed:26876937). May also regulate alternative splice site selection (PubMed:20167602). Also involved in nuclear export of m6A-containing mRNAs via interaction with SRSF3: interaction with SRSF3 facilitates m6A-containing mRNA-binding to both SRSF3 and NXF1, promoting mRNA nuclear export (PubMed:28984244). Also recognizes and binds m6A on other RNA molecules (PubMed:27602518). Involved in random X inactivation mediated by Xist RNA: recognizes and binds m6A-containing Xist and promotes transcription repression activity of Xist (PubMed:27602518). Involved in S- adenosyl-L-methionine homeostasis by regulating expression of MAT2A transcripts, probably by binding m6A-containing MAT2A mRNAs (By similarity). {ECO:0000250|UniProtKB:E9Q5K9, ECO:0000269|PubMed:20167602, ECO:0000269|PubMed:25242552, ECO:0000269|PubMed:26318451, ECO:0000269|PubMed:26876937, ECO:0000269|PubMed:27602518, ECO:0000269|PubMed:28984244}.;
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- loftool
- rvis_EVS
- -0.58
- rvis_percentile_EVS
- 18.59
Haploinsufficiency Scores
- pHI
- 0.252
- hipred
- Y
- hipred_score
- 0.729
- ghis
- 0.686
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.967
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ythdc1
- Phenotype
- endocrine/exocrine gland phenotype; cellular phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- mRNA splice site selection;mRNA export from nucleus;dosage compensation by inactivation of X chromosome;posttranscriptional regulation of gene expression;regulation of mRNA splicing, via spliceosome
- Cellular component
- nucleus;nucleoplasm;plasma membrane;nuclear speck
- Molecular function
- RNA binding;protein binding;N6-methyladenosine-containing RNA binding